| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe256f2e07b1769466465082fbd31ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_094afb218ccf5693aa94a7c9c9f8ab3d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-02019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 |
| filingDate |
2001-08-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d455bf5ea6adcccac2507e2672cbec5e |
| publicationDate |
2002-02-14^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0211672-A2 |
| titleOfInvention |
Transgenic mice containing ubiquitin protein ligase e3 gene disruptions |
| abstract |
The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising mutations in an ubiquitin ligase EC gene. Such transgenic mice are useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03027122-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03027122-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7101667-B2 |
| priorityDate |
2000-08-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |